Date | Title |
2024-12-03 | Week 1, December 2024: Biparatopic Antibodies |
2024-11-26 | Week 4, November 2024: The PD-1, PD-L1, and VEGF Train |
2024-10-08 | Mechanisms of Action of Bispecific Antibodies in Cancer Therapy |
2024-10-04 | September 2024: Bispecific Antibodies in Oncology |
2024-09-20 | What is High-Throughput Expression and Production? |
2024-09-13 | What are Innovative Antibody Formats? |
2024-09-11 | What are Bispecific Antibodies? |
2024-09-09 | 15th World Bispecifics Summit 2024 – Boston: Highlights and Event Recap |
2024-08-09 | Transforming In Vivo Research with Bispecific Antibodies |
2024-07-09 | Week 2, July 2024: An Update on Alzheimer’s Antibody Drugs |
2024-06-21 | The 15th Annual World Bispecific Summit |
2024-05-18 | PEGS 2024 – Boston: Highlights and Event Recap |
2024-05-14 | The Emergence and Evolution of scFvs |
2024-05-08 | Engineered Antibody Formats: A Historical Perspective |
2024-05-02 | Innovating Cancer Treatment: Bispecific Antibody Drug Conjugates |
お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。